Show simple item record

dc.contributor.authorThomas, M.
dc.contributor.authorMortensen, H. R.
dc.contributor.authorHoffmann, L.
dc.contributor.authorMøller, D. S.
dc.contributor.authorTroost, E. G. C.
dc.contributor.authorMuijs, C. T.
dc.contributor.authorBerbee, M.
dc.contributor.authorBütof, R.
dc.contributor.authorNicholas, O.
dc.contributor.authorRadhakrishna, Ganesh
dc.contributor.authorDefraene, G.
dc.contributor.authorNafteux, P.
dc.contributor.authorNordsmark, M.
dc.contributor.authorHaustermans, K.
dc.date.accessioned2021-01-06T11:15:27Z
dc.date.available2021-01-06T11:15:27Z
dc.date.issued2020en
dc.identifier.citationThomas M, Mortensen HR, Hoffmann L, Moller DS, Troost EGC, Muijs CT, et al. Proposal for the delineation of neoadjuvant target volumes in oesophageal cancer. Radiother Oncol. 2020;156:102-12.en
dc.identifier.pmid33285194en
dc.identifier.doi10.1016/j.radonc.2020.11.032en
dc.identifier.urihttp://hdl.handle.net/10541/623650
dc.description.abstractPurpose: To define instructions for delineation of target volumes in the neoadjuvant setting in oesophageal cancer. Materials and methods: Radiation oncologists of five European centres participated in the following consensus process: [1] revision of published (MEDLINE) and national/institutional delineation guidelines; [2] first delineation round of five cases (patient 1-5) according to national/institutional guidelines; [3] consensus meeting to discuss the results of step 1 and 2, followed by a target volume delineation proposal; [4] circulation of proposed instructions for target volume delineation and atlas for feedback; [5] second delineation round of five new cases (patient 6-10) to peer review and validate (two additional centres) the agreed delineation guidelines and atlas; [6] final consensus on the delineation guidelines depicted in an atlas. Target volumes of the delineation rounds were compared between centres by Dice similarity coefficient (DSC) and maximum/mean undirected Hausdorff distances (Hmax/Hmean). Results: In the first delineation round, the consistency between centres was moderate (CTVtotal: DSC=0.59-0.88; Hmean=0.2-0.4cm). Delineations in the second round were much more consistent. Lowest variability was obtained between centres participating in the consensus meeting (CTVtotal: DSC: p<0.050 between rounds for patients 6/7/8/10; Hmean: p<0.050 for patients 7/8/10), compared to validation centres (CTVtotal: DSC: p<0.050 between validation and consensus meeting centres for patients 6/7/8; Hmean: p<0.050 for patients 7/10). A proposal for delineation of target volumes and an atlas were generated. Conclusion: We proposed instructions for target volume delineation and an atlas for the neoadjuvant radiation treatment in oesophageal cancer. These will enable a more uniform delineation of patients in clinical practice and clinical trials.en
dc.language.isoenen
dc.relation.urlhttps://dx.doi.org/10.1016/j.radonc.2020.11.032en
dc.titleProposal for the delineation of neoadjuvant target volumes in oesophageal canceren
dc.typeArticleen
dc.contributor.departmentKU Leuven - University of Leuven, Department of Oncology - Laboratory of Experimental Radiotherapy, Leuven, Belgium; University Hospitals Leuven, Department of Radiation Oncology, Leuven, Belgium.en
dc.identifier.journalRadiotherapy and Oncologyen
dc.description.noteen]


Files in this item

This item appears in the following Collection(s)

Show simple item record